Recombinant human thyrotropin and thyroid cancer management

被引：32

作者：

Robbins, RJ

Robbins, AK

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Div Gen Med, Endocrine Serv, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Med Lib, Nathan Cummings Ctr, New York, NY 10021 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2003年 / 88卷 / 05期

关键词：

D O I：

10.1210/jc.2002-021979

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1933 / 1938

页数：6

共 49 条

[1]

Adler M L, 1998, Endocr Pract, V4, P282

[2]

Aslam S N, 2001, Endocr Pract, V7, P99

[3]

BENUA RS, 1964, J NUCL MED, V5, P796

[4] Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone [J].

Berg, G ;

Lindstedt, G ;

Suurküla, M ;

Jansson, S .

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (01) :44-52

[5]

Bjerke S N, 2001, Tidsskr Nor Laegeforen, V121, P2373

[6] RECOMBINANT HUMAN THYROTROPIN STIMULATES THYROID-FUNCTION AND RADIOACTIVE IODINE UPTAKE IN THE RHESUS-MONKEY [J].

BRAVERMAN, LE ;

PRATT, BM ;

EBNER, S ;

LONGCOPE, C .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (05) :1135-1139

[7] Prognosis and treatment of brain metastases in thyroid carcinoma [J].

Chiu, AC ;

Delpassand, ES ;

Sherman, SI .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) :3637-3642

[8] Isolated thyrotropin deficiency secondary to primary empty sella in a patient with differentiated thyroid carcinoma: An indication for recombinant thyrotropin [J].

Colleran, KM ;

Burge, MR .

THYROID, 1999, 9 (12) :1249-1252

[9] Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer [J].

Durski, JM ;

Weigel, RJ ;

McDougall, IR .

NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (06) :521-528

[10]

Giovanni V, 2002, CLIN ENDOCRINOL, V56, P245

← 1 2 3 4 5 →